chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.58
Sex: M
Vaccine: DTAPIPVHIB, FLU3, PNC13, RV5
Symptoms: Intussusception
Clinical narrative: This spontaneous report as received from a physician refers to a 19 months old male patient. The patient was vaccinated with ROTATEQ (lot number not reported) on an unspecified date. No other co-suspects were reported. No concomitant medications were reported. On 12-OCT-2011 and 18-SEP-2012 the patient experienced two incidents of intussusception and was hospitalized. The hospital was not identified. The patient had sought unspecified medical attention and received unspecified treatment. The outcome of the patient was unknown. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, TDAP
Symptoms: Anaphylactic shock, Resuscitation
Clinical narrative: This spontaneous report as received from a receptionist clerk refers to a 16 years old female patient with prophylaxis. The patient was vaccinated with VAQTA. Suspects therapies included GARDASIL (manufacturer unspecified) and antimicrobial (unspecified). Concomitant therapies Tdap and laryngitis shot. On 04-SEP-2012 (2 weeks ago) the patient experienced anaphylactic shock (hospitalization and life threatening) and once the anaphylactic shock was handled the patient was placed on an antibiotic (manufacturer unspecified) and the patient again went into another anaphylactic shock (hospitalization and life threatening). The outcome of first anaphylactic shock was reported as recovered/resolved. The outcome of second anaphylactic shock is unknown. The relatedness of first anaphylactic shock is unknown for VAQTA and GARDASIL. The relatedness for anaphylactic shock is unknown for GARDASIL and VAQTA. The adverse events were considered medically significant (the patient was underwent CPR) and life threatening by the reporter. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Per mom, began 9/27/12 am with redness, heat, hard (rt) arm. Brought to clinic marked margin & advised monitor & apply cold compress. RR or take if increase size or see new sx. Mom took to regional ER 9/27/12 pm b/c increase size & dev (lt) arm too. Told it poss-allergic rxn or infection given BENADRYL PO also told to monitor and advised if worse or any new sx talk with immed.
Age: 14.0
Sex: F
Vaccine: FLUN3
Symptoms: Full blood count normal, Headache, Metabolic function test normal, Neck pain, Pain
Clinical narrative: Fever, headache, neck and body soreness.
Age: 14.0
Sex: F
Vaccine: FLUN3
Symptoms: Pyrexia
Clinical narrative: Fever, headache, neck and body soreness.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Dizziness, Myalgia, Rash
Clinical narrative: Patient developed rash and muscle tenderness, with burning sensation. Patient also had lightheadedness and dizziness for couple days.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Oedema peripheral, Skin reaction
Clinical narrative: Developed red swollen arm in 12 hrs 4 x 3 inch. Due to previous reaction ask Drs. they said give. Started ADVIL and cold compress over next few days but give shot I cleared with Dr first.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Coordination abnormal, Decreased appetite, Dizziness, Fatigue, Feeling hot
Clinical narrative: Feeling hot w/o a real fever; feel achy, dizziness; loss of coordination; severe headaches, fatigue when performing normal activities (walking from one room to another in my home, taking care of personal hygiene); loss of appetite.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pain
Clinical narrative: Feeling hot w/o a real fever; feel achy, dizziness; loss of coordination; severe headaches, fatigue when performing normal activities (walking from one room to another in my home, taking care of personal hygiene); loss of appetite.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Faecal volume decreased, Frequent bowel movements, Urinary tract infection
Clinical narrative: Dizziness, urinary tract infection, little & frequent bowel movement.
Age: 28.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Muscle fatigue, Pain in extremity
Clinical narrative: Severe pain in left arm. Began roughly 14 hours after injection. Patient arm now in sling due to difficulty with muscle fatigue because of the pain.
Age: 28.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Injected limb mobility decreased, Injection site reaction, Myalgia
Clinical narrative: Severe pain in left arm. Began roughly 14 hours after injection. Patient arm now in sling due to difficulty with muscle fatigue because of the pain.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Burning sensation, Sensory disturbance
Clinical narrative: Complained vaccine was burning - even after needle was pulled out. Stated strange sensation can down arm to neck & jaw - couldn't differentiate pain vs strange sensation. No treatment administered. Pt said she was ok. I called her an hour later - she was running errands but still had a slight off sensation.
Age: 1.0
Sex: U
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from an Office manager registered nurse refers to a patient of 1 years old. The office manager reported that on 27-AUG-2012, the received 0.5 ml dose of GARDASIL injection 120 Y  (Lot#H010428; exp. date: 20-JAN-2012) inadvertently. No adverse effects reported. The outcome of the event was unknown. The event was not related to GARDASIL. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Hypersensitivity
Clinical narrative: This spontaneous report was received from a physician refers to a female patient of unknown age who on an unknown date, in 2012, was vaccinated intramuscularly with the first dose of GARDASIL (dose and lot number not reported) and in July 2012, was vaccinated with the second dose of GARDASIL (dose and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The physician reported that two weeks after first vaccination, in 2012, the patient had an unspecified allergic reaction. The patient went to the emergency room and was given BENADRYL as a treatment for the experience. In approximately July 2012, after second vaccination, the patient displayed the same unspecified allergic reaction. At the time of the report, the patient's outcome was unknown. The relatedness for the patient had an unspecified allergic reaction after first dose of GARDASIL and the patient displayed the same unspecific allergic reaction after second dose of GARDASIL was unknown for GARDASIL. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Condition aggravated, Tourette's disorder
Clinical narrative: This spontaneous report was received from a physician refers to a female patient of an unknown age. Current conditions included Tourette Syndrome. On an unknown date the patient was vaccinated with dose of GARDASIL unspecified doses, route of administration not reported. No concomitant medications were reported. On an unknown date the patient was experiencing flare-up of her Tourettes Syndrome. The reported event did not resolve at the time of this report. Physician refused to provide additional information at the time of this report but she agreed to having follow-up forms sent to her. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of unknown age. It was reported that the patients might have received improperly stored GARDASIL (lot # not reported) which were exposed to 54 F for 96 hours on 04-SEP-2012. No adverse effect was reported. It was unspecified whether the patients sought for medical attention. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 81 years old female patient with "Sulfa" allergy and BIAXIN allergy. On 23-JUL-2012, the patient was vaccinated with ZOSTAVAX (lot#0365AE; exp. Date: 23-MAR-2013). On August 2012, the patient experienced developed red bumps, not itchy or painful at the injection site of a ZOSTAVAX vaccination (date of vaccination: 23-JUL-2012). The red bump at the injection site of a ZOSTAVAX vaccination developed last week (exact date unspecified). The patient contacted the pharmacist today 23-AUG-2012 and the red bumps at the injection site were still present. No treatment was given to the patient. The outcome of the event was reported as not recovered. The relatedness for the event and ZOSTAVAX was unknown. Additional information has been requested.
Age: 46.0
Sex: M
Vaccine: VARCEL
Symptoms: Pain, Rash vesicular
Clinical narrative: This spontaneous report was received from a physician concerning an 46 years old male patient, without pertinent medical history or drug reaction / allergies. The physician reported that on 24-AUG-2012, the patient was vaccinated subcutaneously with the first dose of VARIVAX (Merck) (dose was not reported). No other co-suspects were reported. No concomitant medications were reported. On 15-SEP-2012, the patient developed a varicella like rash, and dermatomal pain following the administration of his first dose of VARIVAX (Merck). The patient came down with 15 chicken pox like blisters last week. The patient was treated with an unspecified antihistamine. There was not laboratory test performed. The patient sought medical attention as office visit. At the time of report, the patient had not recovered. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a patient of unknown age and gender. On 30-AUG-2012, the patient was vaccinated subcutaneously with an expired dose of 0.65 ml of ZOSTAVAX (lot #:670820/0660AA; Expiration date: 04-AUG-2012). There were no adverse events reported. Additional information has been requested.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous report was received from a doctor of pharmacy refers to an approximately 57 year old female patient with no drug reactions or allergies who on an unknown date, was vaccinated intramuscularly in her right arm with a dose of ZOSTAVAX (dose and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that the patient developed pain, redness and swelling in her right arm where the vaccine was administered. The pharmacist mentioned that these symptoms started the day after the patient received the vaccine on an unspecified date and clarified that the vaccine was not administered in her pharmacy. No treatment was given for the experience. No lab diagnostics studies were performed. At the time of the report, the patient was recovering. The patient sought medical attention through the pharmacist. The relatedness for patient developed pain, swelling and redness in her right arm where the vaccine was administered was unknown for ZOSTAVAX. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a 1 year old patient. The patient was vaccinated with a 0.5 ml dose, SC VARIVAX (merck) (Lot #669846/0344AA) on 08-DEC-2011. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced chicken pox. No treatment information was reported. The outcome of chicken pox was unknown. The relatedness for chicken pox was unknown for VARIVAX (Merck). This is one of several reports from the same source. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous report was received from a doctor of pharmacy refers to a 66 years old female patient who on 18-AUG-2012, was vaccinated with a dose of ZOSTAVAX (lot number 5663AE, Exp. Date: 21-MAR-2013) (dose and route not reported). No concomitant medications were reported. The pharmacist reported that on 18-AUG-2012, the patient developed red, swollen, raised and sore area at the injection site after receiving ZOSTAVAX. BENADRYL, TYLENOL and MOTRIN were given as a treatment for the experience. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. The relatedness for red, sore, raised and swollen area at the injection site was unknown for ZOSTAVAX. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: This spontaneous report as received from a consumer concerning his 67 year old wife. The patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX in September 2012. No other co-suspects were reported. No concomitant medications were reported. In September 2012, the patient experienced red rash at injection site. No treatment information was provided. The patient did not seek medical attention. No laboratory tests were performed. The outcome of red rash at injection site was reported as recovering/resolving. The relatedness for red rash at injection site was unknown for ZOSTAVAX. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown age. On an unspecified date, the patients were vaccinated with a dose of VARIVAX (Merck) lot # (670338/0467AA, exp date 31-MAR-2012) (dose and route not reported). It was reported that VARIVAX (Merck) vials had been stored at temperatures ranging 6-8 F for unspecified among of time since receiving the vaccine and some doses were administered to the patient. There were no adverse effects reported. Additional information is not expected.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of unknown age. It was reported that the patients might have received improperly stored liquid PEDVAXHIB (lot # not reported) which were exposed to 54 F for 96 hours on 04-SEP-2012. No adverse effect was reported. It was unspecified whether the patients sought for medical attention. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of unknown age. It was reported that the patients might have received improperly stored M-M-R II (lot # not reported) which were exposed to 54 F for 96 hours on 04-SEP-2012. No adverse effect was reported. It was unspecified whether the patients sought for medical attention. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 0.37
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1, DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Electroencephalogram, Hemiparesis, Hypotonia, Mental status changes, Nuclear magnetic resonance imaging brain
Clinical narrative: Shock like state. Non responsive. Limp. Brought child to emergency room.
Age: 0.37
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1, DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Electroencephalogram abnormal, Hypotonia, Mobility decreased, Nervous system disorder, Shock
Clinical narrative: Shock like state. Non responsive. Limp. Brought child to emergency room.
Age: 0.37
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1, DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Unresponsive to stimuli
Clinical narrative: Shock like state. Non responsive. Limp. Brought child to emergency room.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Chest discomfort, Fatigue, Oropharyngeal pain, Pain, Productive cough
Clinical narrative: Vaccination is required by employer. If you decline vaccination they make you wear a mask for months so you basically have no choice but to receive the vaccine. Vaccine was administered with a safety syringe which malfunctioned, causing the needle be retracted from my arm during injection. I felt the vaccine run down my arm and the nurse said that I had to have it again so I was injected a second time. Don't know how much I actually received during the first injection. Within the next 3 hours I developed a productive cough with chest tightness, sore throat and fever, had general body aches and fatigue that lasted about 24 hours.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia, Syringe issue
Clinical narrative: Vaccination is required by employer. If you decline vaccination they make you wear a mask for months so you basically have no choice but to receive the vaccine. Vaccine was administered with a safety syringe which malfunctioned, causing the needle be retracted from my arm during injection. I felt the vaccine run down my arm and the nurse said that I had to have it again so I was injected a second time. Don't know how much I actually received during the first injection. Within the next 3 hours I developed a productive cough with chest tightness, sore throat and fever, had general body aches and fatigue that lasted about 24 hours.
Age: 45.0
Sex: M
Vaccine: TD
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: Fever 100, chills, bilateral upper and lower extremity pain.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Dizziness
Clinical narrative: Patient comes to immediate care center today after receiving flu vaccine at pharmacy yesterday. Patient states that she began to feel dizzy and weak approximately 4 hours after receiving the vaccine.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Smear cervix abnormal
Clinical narrative: I had always had healthy PAP screens that can be normal until I received the Gardasil vaccine. Now I have received my second abnormal PAP. I believe that the vaccine has been the cause of these abnormal results.
Age: 28.0
Sex: F
Vaccine: MEN
Symptoms: Contusion, Induration, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt began to notice soreness and extreme tenderness at injection site the same evening of the vaccination. They were unable to sleep on that side of their arm. It felt as if it were bruised. That soreness and tenderness has still not resolved as of today, 9/30/12, and pt can still not sleep on left side. They also have a 3.5cm oval red spot where injection was given, which appeared the evening of the injection day and has still not resolved. The red spot is warm to the touch. Pt's most concerning symptom is a knot/lump that developed the day after receiving the shot (9/28). The knot is located just beneath the skin on top of the collarbone, about midway. It is approximately 2cm in size and is mostly round. It is extremely painful to touch, but is mostly is moveable, even though it feels quite firm.
Age: 28.0
Sex: F
Vaccine: MEN
Symptoms: Nodule
Clinical narrative: Pt began to notice soreness and extreme tenderness at injection site the same evening of the vaccination. They were unable to sleep on that side of their arm. It felt as if it were bruised. That soreness and tenderness has still not resolved as of today, 9/30/12, and pt can still not sleep on left side. They also have a 3.5cm oval red spot where injection was given, which appeared the evening of the injection day and has still not resolved. The red spot is warm to the touch. Pt's most concerning symptom is a knot/lump that developed the day after receiving the shot (9/28). The knot is located just beneath the skin on top of the collarbone, about midway. It is approximately 2cm in size and is mostly round. It is extremely painful to touch, but is mostly is moveable, even though it feels quite firm.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Rash generalised, Urticaria
Clinical narrative: Rash and hives all over body, saw ER doctor on 9/30.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Heart rate increased, Rhinorrhoea
Clinical narrative: Severe chills, runny nose, and rapid heartbeat. Pt states symptoms resolved after 30 minutes. Pt did not seek medical attention.
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Balance disorder, Nasopharyngitis
Clinical narrative: Cold symptoms loss of balance.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Vaccination site haematoma
Clinical narrative: Bruising about size of a penny at site of vaccination.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Balance disorder, Blood pressure increased, Dizziness, Headache
Clinical narrative: Dizziness upon waking, inability to focus, nausea, headache, unsteadiness, blood pressure higher than normal, pulse faster than normal, weakness, pallid.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Heart rate increased, Nausea, Pallor, Vision blurred
Clinical narrative: Dizziness upon waking, inability to focus, nausea, headache, unsteadiness, blood pressure higher than normal, pulse faster than normal, weakness, pallid.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Blindness, Chills, Dizziness, Headache, Nausea
Clinical narrative: Nausea, retching, chills, headache, vision loss, dizziness.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Retching
Clinical narrative: Nausea, retching, chills, headache, vision loss, dizziness.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Loss of consciousness, Syncope
Clinical narrative: Fainted and blacked out about 5-10 minutes after receiving the shot. Lasted about 30 seconds-1 minute in duration. Mom is a NP, and patient was caught by mom and did not fall or hit his head. 911 service was offered, but patient's mom declined and said this has happened before.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Allergy test, Asthma, Biopsy kidney, Biopsy lymph gland, Blood test
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Cough, Decreased appetite, Dialysis, Fatigue
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: HIV test, Hepatitis A virus test, Hepatitis B virus test, Hepatitis C virus test, Hypersensitivity
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Immune system disorder, Inflammation, Laboratory test, Lobar pneumonia, Lymphadenopathy
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Malaise, Mycobacterium tuberculosis complex test, Pyrexia, Renal failure acute, Skin test
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Spirometry
Clinical narrative: 11/5/11: Fever, cough, ill feeling, 3 days.  Cough remained and became chronic.   11/23-11/26/11: fever, chills, cough, extreme fatigue, loss of appetite. 12/23-12/25/11: 2nd episode fever, chills, cough, extreme fatigue, loss of appetite.   1/3/12-1/6/12: 3rd episode fever, chills, cough, extreme fatigue, loss of appetite.  Fever to 102.6.   January 2012:  Cough becomes more severe. 2/8/12:  Pulmonologist diagnoses asthma, allergies and prescribes meds for both.  No respritory allergies ever found. 3/24-3/26/12:  4th episode fever, chills, cough, extreme fatigue, loss of appetite. 5/9-5/18/12:  5th episode fever, chills, extreme fatigue. SEVERE!  Acute kidney failure, hospitalization, dialysis.  Mediastienum lymph nodes enlarged.  Kidney and lymph node biopsy.   6/21/12:  Dialysis ended. 7/1/12:  Lower right lobe pneumonia 7/26: End long tapered course of prednisone. 8/22/12:  Appt. Determined no asthma, allergies, vasculitis or sarcoidosis.  Refered to CBCI for consultation on t cell clone from 5/22 lymph node biopsy.  Determined to be a reactive clone.  No other lymphoma signs present.  Dr. suspects from event timing that influenza vaccine sent immune system into "hyper drive" and that prednisone has allowed inflammation to decrease and immune system to adjust.  Also suspects meds for asthma and allergies triggered kidney failure.  Advised to not get influenza shots again. 9/30/12:  No signs of asthma cough or allergies.  Recovery continues.  Strength and pulmonary function continues to increase.  Pulmonary, kidney and oncology follow up appts scheduled for 10/2012.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Fatigue, Injection site erythema
Clinical narrative: REDNESS AT SITE, PATIENT FEELING WEAK AND TIRED.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site warmth, Rash erythematous
Clinical narrative: LOCAL RASH THAT WAS RED, ROUND, PAINFUL AND HOT ON MID TO UPPER LEFT ARM.
Age: 24.0
Sex: M
Vaccine: FLUN3
Symptoms: Chest pain, Dizziness, Dyspnoea, Loss of consciousness, Nausea
Clinical narrative: Chest pain, shortness of breath, nausea, lightheadedness; brief loss of consciousness. Diagnosed with pericarditis.
Age: 24.0
Sex: M
Vaccine: FLUN3
Symptoms: Pericarditis
Clinical narrative: Chest pain, shortness of breath, nausea, lightheadedness; brief loss of consciousness. Diagnosed with pericarditis.
Age: 93.0
Sex: M
Vaccine: FLU3
Symptoms: Faeces discoloured, Haematochezia, Haemorrhage, Hyperhidrosis, Incorrect dose administered
Clinical narrative: Sweating, bloody stools, nausea.  Is currently a patient, as they do not know where he is bleeding from.  Currently in the ICU.
Age: 93.0
Sex: M
Vaccine: FLU3
Symptoms: Intensive care, Nausea
Clinical narrative: Sweating, bloody stools, nausea.  Is currently a patient, as they do not know where he is bleeding from.  Currently in the ICU.
Age: 66.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Pt developed red circular rash at ZOSTAVAX injection site. Pt stated rash onset day after vaccine. Rash small on that date. Dime sized. Rash evolved to silver dollar sized. 2 days after vaccine. Rash appeared red, circular and not raised. No complaints apart from red rash, minor itching.
Age: 67.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Inflammation, Oedema peripheral
Clinical narrative: Inflamed and swollen left arm 4 days. Take BENADRYL 50mg q 4 H x 2 days.
Age: 46.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth
Clinical narrative: Patient noticed 2 days after injection - her arm started to get inflamed at site of injection. Her arm was red and inflamed, and warm to touch at the site of injection. (Right arm).
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Eating disorder, Swollen tongue, Tongue exfoliation
Clinical narrative: Swollen tongue, tongue peeled, could not eat hot food. Did not go to hospital or seek treatment.
Age: 61.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Patient received PNEUMOVAX 23 vaccine on 9/24/12, but already received PNEUMOVAX 23 last year on 10/4/2011. Patient complaining high fever, sore arm, fatigue, headache. Called primary MD who said to take TYLENOL. Also called Merck manufacturer.
Age: 61.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Fatigue, Pyrexia
Clinical narrative: Patient received PNEUMOVAX 23 vaccine on 9/24/12, but already received PNEUMOVAX 23 last year on 10/4/2011. Patient complaining high fever, sore arm, fatigue, headache. Called primary MD who said to take TYLENOL. Also called Merck manufacturer.
Age: 51.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site nodule, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, muscle knot, warmth at injection site, and pain at injection site.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Induration, Skin warm, Swelling
Clinical narrative: Swelling, red, hard & warm to touch.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Dehydration, Hyperhidrosis, Hypoglycaemia, Loss of consciousness, Pallor
Clinical narrative: Roughly 5 min. after administration patient became white in the face and lips, began to sweat profusely, and then lost consciousness for about 10 sec. Pt. regained consc. for a few min and lost cons. again for about 20 sec. Pt. was asked series of questions to remain alert until paramedics arrived 5-10 min later. Suspected dehydration and hypoglycemia.
Age: 12.0
Sex: M
Vaccine: FLU3, HEPA, IPV, MNQ
Symptoms: Erythema, Oedema
Clinical narrative: Marked erythema/edema (about 5x/5 cm) starting 24 hrs after injection extending down arm (R). Pt started on po Clindamycin x 10 days. Pt afebrile.
Age: 83.0
Sex: F
Vaccine: FLU3
Symptoms: Apparent life threatening event, Cough, Dysphagia, Headache, Myalgia
Clinical narrative: Pt. called on 9/26 stating pt. had life threatening rxn to FLUZONE HD. Called pt. 9/30 to follow up, stated muscle pain, fainting, nausea, HA, cough, trouble swallowing. Took BENADRYL, went to doctor. Had flu shot before, not HD. 9/30 pt. stated feeling better but not 100%.
Age: 83.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Syncope, Vaccination complication
Clinical narrative: Pt. called on 9/26 stating pt. had life threatening rxn to FLUZONE HD. Called pt. 9/30 to follow up, stated muscle pain, fainting, nausea, HA, cough, trouble swallowing. Took BENADRYL, went to doctor. Had flu shot before, not HD. 9/30 pt. stated feeling better but not 100%.
Age: 26.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site warmth
Clinical narrative: Patient reported heat and pain at injection site patient taking ibuprofen.
Age: 67.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Red and swollen at injection site hot to touch and hard at site of PNEUMOVAX. Advised pt to take ibuprofen and BENADRYL and put ice on it.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Lip swelling
Clinical narrative: Pt. went to ER complained of swollen lips.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus generalised
Clinical narrative: Patient received vaccine in the afternoon on 9/27/11. About 18 hours later started 'itching from head to toe". Had an appointment 9/28 with Dr. to discuss new diagnosis with Lymphoma. He wasn't concerned - told her to try HC cream. Seemed to help. Trying BENADRYL.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Cough, Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report as received from a 80 years old female patient with cataracts both eyes and rheumatoid arthritis concerning herself. The patient's medical history included both hips replaced. The patient was vaccinated with ZOSTAVAX (lot # was unknown) on 30-AUG-2012 to prevent shingles. Concomitant medications included VYTORIN, DIOVAN, ANSAID, ULTRACEF and MEXATE. On 30-AUG-20912 the patient had the ZOSTAVAX and developed redness and swelling at the injection site. The next day it was still red. By the third day 1-SEP-2012, she developed a cough which she still had. She had been calling the doctor's office, but had not been able to get an appointment. No treatment information was reported. Blood work for rheumatoid arthritis every 2 months, the result was unknown. The outcome of cough, swelling at the injection site and redness at the injection site was reported as not recovered/not resolved. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: JEV1, TDAP, TYP, JEV1, TDAP, TYP
Symptoms: Abdominal pain upper, Acute myeloid leukaemia, Blood test normal, Headache, Hyperhidrosis
Clinical narrative: The following information was downloaded from VAERS on 18 Sep 2012. A 48 year old female received IXIARO batch number JEV10J64E) i.m. into the left arm on 12 Mar 2012. Concomitant vaccination included typhoid vaccine and TdaP. Concomitant medication included hydrochlorothiazide and vitamin D. Blood tests performed during vaccination [not specified] were normal. Medical history includes drug allergies to penicillin and tetracycline, and mild hypertension. On 30 June 2012 she experienced headache, sweats, right upper quadrant pain, and was ultimately diagnosed with acute myeloid leukaemia. She was hospitalized for 27 days. Reporter concluded that leukaemia diagnosis was considered coincidental, and the he did not know who else to report to.
Age: 48.0
Sex: F
Vaccine: JEV1, TDAP, TYP, JEV1, TDAP, TYP
Symptoms: Abdominal pain upper, Acute myeloid leukaemia, Headache, Hyperhidrosis
Clinical narrative: The following information was downloaded from VAERS on 18 Sep 2012. A 48 year old female received IXIARO batch number JEV10J64E) i.m. into the left arm on 12 Mar 2012. Concomitant vaccination included typhoid vaccine and TdaP. Concomitant medication included hydrochlorothiazide and vitamin D. Blood tests performed during vaccination [not specified] were normal. Medical history includes drug allergies to penicillin and tetracycline, and mild hypertension. On 30 June 2012 she experienced headache, sweats, right upper quadrant pain, and was ultimately diagnosed with acute myeloid leukaemia. She was hospitalized for 27 days. Reporter concluded that leukaemia diagnosis was considered coincidental, and the he did not know who else to report to.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Pain, Rash vesicular, Skin warm
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 65 years old female patient. The patient was vaccinated with a dose of ZOSTAVAX (lot#, dose and route not reported) on 15-AUG-2012. On 16-AUG-2012 the patient experienced redness at the injection site, 2 days after onset of therapy. On 17-AUG-2012 the patient developed a rash at the injection site ("she believes there is a rash developing") and she believed that her injection site was more red. The patient sought medical attention by consulted pharmacist. No treatment was given. At the time of report the patient status was not recovered. The relatedness for "redness at the injection site and there is a rash developing" were unknown for ZOSTAVAX. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 65 years old female patient. The patient was vaccinated with a dose of ZOSTAVAX (lot#, dose and route not reported) on 15-AUG-2012. On 16-AUG-2012 the patient experienced redness at the injection site, 2 days after onset of therapy. On 17-AUG-2012 the patient developed a rash at the injection site ("she believes there is a rash developing") and she believed that her injection site was more red. The patient sought medical attention by consulted pharmacist. No treatment was given. At the time of report the patient status was not recovered. The relatedness for "redness at the injection site and there is a rash developing" were unknown for ZOSTAVAX. Additional information has been requested.
Age: 1.83
Sex: M
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Culture stool, Diarrhoea, Dysphemia, Parasite stool test, Pyrexia
Clinical narrative: This spontaneous report was received from a nurse refers to a 23 months old male patient. On 05-SEP-2012, the patient was vaccinated subcutaneously with dose 1, 0.5 ml VARIVAX lot number (0612AE, expiry-March 2014) and 0.5 ml of MMR II lot number (0008AE, expiry-December 2012). No concomitant medications were reported. On 06-SEP-2012, the patient experienced diarrhea and fever of 104F. The patient was evaluated in a local emergency room on 08-SEP-2012 and was prescribed MOXICILLIN. The patient was seen in the office on 13-SEP-2012 and a stool specimen was sent for culture, results pending. The patient was directed to complete the course of AMOXICILLIN. The outcome of diarrhea and fever of 104F was reported as recovering. The relatedness for diarrhea and fever of 104F was unknown for MMR II and VARIVAX. Lot number verification has been requested. Additional information has been requested.
Age: 1.83
Sex: M
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Culture stool, Diarrhoea, Pyrexia
Clinical narrative: This spontaneous report was received from a nurse refers to a 23 months old male patient. On 05-SEP-2012, the patient was vaccinated subcutaneously with dose 1, 0.5 ml VARIVAX lot number (0612AE, expiry-March 2014) and 0.5 ml of MMR II lot number (0008AE, expiry-December 2012). No concomitant medications were reported. On 06-SEP-2012, the patient experienced diarrhea and fever of 104F. The patient was evaluated in a local emergency room on 08-SEP-2012 and was prescribed MOXICILLIN. The patient was seen in the office on 13-SEP-2012 and a stool specimen was sent for culture, results pending. The patient was directed to complete the course of AMOXICILLIN. The outcome of diarrhea and fever of 104F was reported as recovering. The relatedness for diarrhea and fever of 104F was unknown for MMR II and VARIVAX. Lot number verification has been requested. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Arthralgia, Asthenia, Borrelia test negative, Chills, Computerised tomogram head normal
Clinical narrative: This spontaneous report as received from a medical student refers to a 64 years old male patient with diabetes, hypertension and hyperlipidaemia and a medical history of COPD. On 14-SEP-2012, the patient was vaccinated intramuscular (IM) in left upper arm with 0.5 ml PNEUMOVAX23 lot # (1947AA) Exp: 20-OCT-2013. Concomitant medications included aspirin, diclofenac, FLOVENT, albuterol sulfate, COMBIVENT, losartan potassium, omeprazole and verapamil. The medical student reporting that on 14-SEP-2012 the patient, who was administered his first dose of PNEUMOVAX23 lot # (1947AA) developed fever, chills, myalgia, arthralgia, headache, weakness, and nausea on 15-SEP-2012. On 16-SEP-2012, the patient was seen in a local emergency room. A complete blood count revealed leukocytosis of 22.6 and a lumbar puncture and CT scan of the brain were normal. the patient did not require hospitalization. On 17-SEP-2012, the patient developed erythema and swelling of the left upper arm. On 18-SEP-2012, the patient was evaluated in the office and was prescribed BACTRIM for possible cellulitis. The patient was on 20-SEP-2012, and was recovering. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Headache, Injection site rash, Injection site swelling, Leukocytosis, Lumbar puncture normal
Clinical narrative: This spontaneous report as received from a medical student refers to a 64 years old male patient with diabetes, hypertension and hyperlipidaemia and a medical history of COPD. On 14-SEP-2012, the patient was vaccinated intramuscular (IM) in left upper arm with 0.5 ml PNEUMOVAX23 lot # (1947AA) Exp: 20-OCT-2013. Concomitant medications included aspirin, diclofenac, FLOVENT, albuterol sulfate, COMBIVENT, losartan potassium, omeprazole and verapamil. The medical student reporting that on 14-SEP-2012 the patient, who was administered his first dose of PNEUMOVAX23 lot # (1947AA) developed fever, chills, myalgia, arthralgia, headache, weakness, and nausea on 15-SEP-2012. On 16-SEP-2012, the patient was seen in a local emergency room. A complete blood count revealed leukocytosis of 22.6 and a lumbar puncture and CT scan of the brain were normal. the patient did not require hospitalization. On 17-SEP-2012, the patient developed erythema and swelling of the left upper arm. On 18-SEP-2012, the patient was evaluated in the office and was prescribed BACTRIM for possible cellulitis. The patient was on 20-SEP-2012, and was recovering. Additional information has been requested.